"Understanding how the drug supply car can greatly enhance an adjuvant immune reaction is something which could be really useful in developing new vaccines," suggests Ana Jaklenec, a principal investigator at MIT's Koch Institute for Integrative Cancer Analysis and among the list of senior authors of the new research.Mainly because of the existence